INCY
Incyte CorporationNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$19.41B
P/E Ratio
13.72
EPS
$7.08
Beta
0.80
52W High
$112.29
52W Low
$63.92
50-Day MA
$95.53
200-Day MA
$95.35
Dividend Yield
—
Profit Margin
26.70%
Forward P/E
12.63
PEG Ratio
0.36
About Incyte Corporation
Incyte Corp is an American pharmaceutical company based in Alapocas, Delaware.
Fundamentals
| Revenue (TTM) | $5.36B |
| Gross Profit (TTM) | $2.83B |
| EBITDA | $1.55B |
| Operating Margin | 25.60% |
| Return on Equity | 30.80% |
| Return on Assets | 13.90% |
| Revenue/Share (TTM) | $27.27 |
| Book Value | $28.12 |
| Price-to-Book | 3.45 |
| Price-to-Sales (TTM) | 3.62 |
| EV/Revenue | 2.879 |
| EV/EBITDA | 8.25 |
| Quarterly Earnings Growth (YoY) | 83.80% |
| Quarterly Revenue Growth (YoY) | 20.90% |
| Shares Outstanding | $199.78M |
| Float | $167.82M |
| % Insiders | 1.89% |
| % Institutions | 106.50% |
Historical Volatility
HV 10-Day
20.11%
HV 20-Day
26.10%
HV 30-Day
24.93%
HV 60-Day
25.06%
HV Rank
15.5%
Volatility is currently contracting
Analyst Ratings
Consensus ($107.96 target)
2
Strong Buy9
Buy13
Hold1
Sell1
Strong SellMore HEALTHCARE Stocks
Data last updated: 5/25/2026